CompanyGraph
Pilot Corp.
7846 · Japan
Price data from its W53 listing on FSX, quoted in EUR
pilot.co.jpFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.16B, above the global median of $1.15B
- PositionOperating margin is 23.9%, higher than 95% of its Business Equipment & Supplies peers (median 6.9%)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.11%Below 5Y avg (2.11%)
Annual Rate
JPY 42.00Paid semi-annual
Payout Ratio
30.2%Sustainable
Payback Period
0.2 yr
Next Ex-Dividend
Dec 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
184.69BJPY1.16B · vs all stocks (USD)
Trailing P/E
14.20xvs Business Equipment & Supplies peers
Revenue (TTM)
133.69BJPY840.57M · vs all stocks (USD)
Profit Margin
11.00%vs Business Equipment & Supplies peers
Beta
-0.2670xvs all stocks
52-Week Change
28.90%vs all stocks
Forward Annual Dividend Yield
2.11%vs all stocks
Market Capitalization
184.69BJPY1.16B · vs all stocks (USD)
Enterprise Value
174.35BJPY1.10B · vs all stocks (USD)
Trailing P/E
14.20xvs Business Equipment & Supplies peers
Forward P/E
4.98xvs Business Equipment & Supplies peers
Price to Sales (TTM)
1.51xvs Business Equipment & Supplies peers
Price to Book (MRQ)
1.39xvs Business Equipment & Supplies peers
Enterprise to Revenue
1.30xvs Business Equipment & Supplies peers
Enterprise to EBITDA
6.86xvs Business Equipment & Supplies peers
Profit Margin
11.00%vs Business Equipment & Supplies peers
Operating Margin
23.85%vs Business Equipment & Supplies peers
Return on Assets (TTM)
6.48%vs Business Equipment & Supplies peers
Return on Equity (TTM)
10.20%vs Business Equipment & Supplies peers
Revenue (TTM)
133.69BJPY840.57M · vs all stocks (USD)
Revenue per Share (TTM)
1.22KJPYUpdated Aug 21, 2026Quarterly Revenue Growth
13.60%vs Business Equipment & Supplies peers
Gross Profit (TTM)
67.89BJPY426.84M · vs all stocks (USD)
EBITDA (TTM)
24.08BJPY151.41M · vs all stocks (USD)
Net Income (TTM)
14.71BJPY92.49M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
31.40%vs Business Equipment & Supplies peers
Operating Cash Flow (TTM)
17.17BJPY107.95M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
6.15BJPY38.68M · vs all stocks (USD)
Forward Annual Dividend Rate
42.00JPYUpdated Aug 21, 2026Forward Annual Dividend Yield
2.11%vs all stocks
Trailing Annual Dividend Rate
41.00JPYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.06%vs all stocks
5-Year Average Dividend Yield
2.11%vs all stocks
Payout Ratio
30.22%vs Business Equipment & Supplies peers
Minority Interest (Equity)
634.00MJPYFY2025 · Dec 31, 2025Revenue
126.39BJPYFY2025 · Dec 31, 2025Cost of Goods Sold
61.94BJPYFY2025 · Dec 31, 2025Gross Profit
64.45BJPYFY2025 · Dec 31, 2025Operating Income
16.65BJPY104.69M · vs all stocks (USD)
Pre-tax Income
18.55BJPYFY2025 · Dec 31, 2025Income Tax Expense
6.40BJPYFY2025 · Dec 31, 2025Net Income
12.14BJPYFY2025 · Dec 31, 2025EBIT
18.63BJPYFY2025 · Dec 31, 2025EBITDA (Income Statement)
24.08BJPYFY2025 · Dec 31, 2025Non-operating Interest Income
783.00MJPYFY2025 · Dec 31, 2025Non-operating Interest Expense
83.00MJPYFY2025 · Dec 31, 2025EPS (Basic)
317.02JPYFY2025 · Dec 31, 2025EPS (Diluted)
317.02JPYFY2025 · Dec 31, 2025Basic Shares Outstanding
38.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
38.05MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-77.00MJPYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00JPYFY2025 · Dec 31, 2025Operating Cash Flow
18.69BJPYFY2025 · Dec 31, 2025Free Cash Flow
7.52BJPYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
38.58BJPYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
18.55BJPYFY2025 · Dec 31, 2025Other Non-cash Items
-793.00MJPYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
328.00MJPYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
614.00MJPYFY2025 · Dec 31, 2025Capital Expenditures
-11.17BJPYFY2025 · Dec 31, 2025Net Intangibles (CF)
-264.00MJPYFY2025 · Dec 31, 2025Net Acquisitions
0.00JPYFY2025 · Dec 31, 2025Purchase of Investments
-612.00MJPYFY2025 · Dec 31, 2025Sale of Investments
1.63BJPYFY2025 · Dec 31, 2025Other Investing Activity
-700.00MJPYFY2025 · Dec 31, 2025Net Investing Cash Flow
-10.86BJPYFY2025 · Dec 31, 2025Long-term Debt Issuance
4.00BJPYFY2025 · Dec 31, 2025Long-term Debt Payments
-319.00MJPYFY2025 · Dec 31, 2025Net Short-term Debt Issuance
246.00MJPYFY2025 · Dec 31, 2025Common Stock Repurchase
-6.01BJPYFY2025 · Dec 31, 2025Common Dividends Paid
-4.76BJPYFY2025 · Dec 31, 2025Other Financing Charges
-506.00MJPYFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.32BJPYFY2025 · Dec 31, 2025Shares Outstanding
105.01MSharesUpdated Aug 21, 2026Float Shares
99.45MSharesUpdated Aug 21, 2026% Held by Insiders
9.69%vs all stocks
% Held by Institutions
35.34%vs all stocks
Total Cash (MRQ)
34.42BJPY216.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
327.77JPYUpdated Aug 21, 2026Total Debt (MRQ)
6.33BJPY39.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0434xvs Business Equipment & Supplies peers
Current Ratio (MRQ)
3.42xvs Business Equipment & Supplies peers
Book Value per Share (MRQ)
1.38KJPYUpdated Aug 21, 2026Total Assets
179.90BJPY1.13B · vs all stocks (USD)
Total Current Assets
110.25BJPYFY2025 · Dec 31, 2025Total Liabilities
33.83BJPYFY2025 · Dec 31, 2025Total Non-current Assets
69.66BJPYFY2025 · Dec 31, 2025Total Non-current Liabilities
6.54BJPYFY2025 · Dec 31, 2025Total Current Liabilities
27.29BJPYFY2025 · Dec 31, 2025Cash & Cash Equivalents
39.99BJPYFY2025 · Dec 31, 2025Accounts Receivable
26.43BJPYFY2025 · Dec 31, 2025Inventory
38.31BJPYFY2025 · Dec 31, 2025Accounts Payable
10.74BJPYFY2025 · Dec 31, 2025Short-term Debt
748.00MJPYFY2025 · Dec 31, 2025Other Current Liabilities
9.70BJPYFY2025 · Dec 31, 2025Long-term Debt
4.00BJPYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.03BJPYFY2025 · Dec 31, 2025Common Stock (Book)
2.34BJPYFY2025 · Dec 31, 2025Retained Earnings
143.51BJPYFY2025 · Dec 31, 2025Total Shareholders' Equity
146.08BJPY918.47M · vs all stocks (USD)
Treasury Stock
16.63BJPYFY2025 · Dec 31, 202552-Week Low
1.48KJPYUpdated Aug 21, 202652-Week High
2.04KJPYUpdated Aug 21, 202652-Week Change
28.90%vs all stocks
Beta
-0.2670xvs all stocks
50-Day MA
1.77KJPYUpdated Aug 21, 2026200-Day MA
1.64KJPYUpdated Aug 21, 2026Avg 10-Day Volume
249.74KSharesUpdated Aug 21, 2026Avg 30-Day Volume
214.10KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
135.69JPYUpdated Aug 21, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 23.9%, higher than 95% of its Business Equipment & Supplies peers (median 6.9%)Significant
Operating margin: 0.24Industry median: 0.07Industry P95: 0.22Peers compared: 30.00
Financial Health
Altman Z-Score 5.99: safe zoneNotable
Altman Z-Score: 5.99
High earnings qualityNotable
Earnings Quality Score: 0.81
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.16B, above the global median of $1.15BNotable
Market cap (USD): 1,161,244,660.121Global Median: 1,146,734,693.424
Revenue is $840.57M, above the global median of $520.53MNotable
Revenue (USD): 840,570,388.041Global Median: 520,528,949.311
Levered free cash flow is $38.68M, above the global median of $16.24MNotable
Levered free cash flow (USD): 38,676,598.997Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Olectra Greentech Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Netcare Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Feng Hsin Steel Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Freewon China Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eyebright Medical Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Shin Zu Shing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hainan Drinda New Energy Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Mys Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRiskFlow
Zhejiang Taihua New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Wanliyang Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Keeper Technical Laboratory
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin
Anest Iwata Corporation
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin
Xiamen Amoytop Biotech Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin